Curated from medtech publications. Product launches, FDA clearances, M&A, technology shifts — rewritten as short briefs, linked back to the source. Filter by theme below.
Stevanato Group launched Deora, a multi-use, fixed-dose pen injector for subcutaneous delivery of diabetes and weight-management therapies. The device is positioned for use across multiple drug development programs.
Dexcom presented data on its G7 continuous glucose monitoring system showing efficacy in type 2 diabetes patients not requiring insulin therapy. The company expects the findings may influence clinical practice patterns for this patient population.
Roche has developed a research-use-only (RUO) PCR assay for rapid detection of Ebola Bundibugyo virus. The molecular test leverages Roche's existing PCR platform capabilities to address detection of this rare viral variant.
Edwards Lifesciences received FDA approval in May 2026 for Triformis Resilia, the first surgical valve designed specifically for the tricuspid position. The device incorporates a design modification that addresses an unmet clinical need in tricuspid valve replacement, marking a new product entry in the structural heart device market.
Insulet has begun distributing an updated version of its Omnipod 5 automated insulin delivery system across the US following 510(k) regulatory clearance in December 2025. The update includes algorithm improvements to the closed-loop control system.
HeartBeam reported positive study data supporting an indication expansion of its ECG device into heart attack detection. The data advance the scientific foundation for the company's planned product expansion, though specific clinical endpoints and timeline for regulatory submission were not detailed in the announcement.
Stryker launched TPX HD, a small bone power tool designed for orthopaedic procedures including total joint revisions, minimally invasive surgery, and oral maxillofacial operations. The tool expands Stryker's surgical instrument portfolio for complex bone work.
SS Innovations CEO Dr. Sudhir Srivastava outlined plans for a flying surgical robot, the Vimana Aero drone, targeting mid-2026 launch. The company unveiled a conceptual design in April and is working through engineering and regulatory challenges to develop an autonomous aerial platform for surgical applications.
Abbott presented data from a prospective sub-study of the PARTNER trial at ASCO26, demonstrating the clinical utility of its MRD (minimal residual disease) test in predicting triple-negative breast cancer recurrence. The findings support the diagnostic value of Abbott's molecular assay in identifying patients at risk of recurrence following treatment.
Made Scientific will manufacture NOVAKnee, a biologic total knee replacement implant, for use in a Phase I clinical study in the US. The announcement signals progression of the device toward human trials, though specific clinical details and regulatory pathway remain unspecified in the source.
MicroPort CardioFlow has launched its LBBOT Solution commercially in Europe and Australia following regulatory approvals. The solution addresses left bundle branch block treatment, expanding the vendor's cardiac care portfolio in international markets.
Philips has partnered with Disney to integrate Disney characters and storytelling into its Ambient Experience platform for pediatric MRI systems. The initiative, building on Philips' existing ambient experience technology from the early 2000s, aims to reduce anxiety and improve the scanning experience for child patients by embedding Mickey Mouse, Yoda, and other Disney IP into medical facility environments.
Veracyte presented clinical data on its Prosigna genomic assay for breast cancer treatment planning at ASCO 2026, alongside findings from GRAIL's multi-cancer early detection test. The data highlighted the assays' utility in guiding therapy selection and enabling earlier cancer identification, supporting their role in precision oncology and screening workflows.
Illumina and SPT Labtech launched fireflyGO, an automation platform designed to streamline targeted oncology research workflows. The system combines Illumina's sequencing capabilities with SPT Labtech's laboratory automation expertise to reduce manual steps and accelerate sample processing for oncology applications.
Philips has partnered with Disney to develop an ambient experience for children undergoing MRI procedures. The collaboration aims to reduce anxiety and improve the patient experience during diagnostic imaging by integrating Disney content and theming into the MRI environment.
Oura announced Ring 5, the next generation of its wearable health-tracking ring. The device is 40% smaller than Ring 4, offers one-week battery life, and features LEDs four times stronger than previous models to improve reading accuracy. New health features powered by AI are included, though specific predictive capabilities were not detailed in the announcement.
LEMO introduced the REDEL P Disposable Plastic Connectors, engineered for electro-surgical and disposable medical applications. The connectors combine LEMO's Push-Pull locking system with a disposable patient-side interface designed for high-volume medical use where reliable connectivity and safe integration are priorities.
Hyperfine reported that its Swoop portable MRI system achieved a median imaging order-to-scan time of 6.35 hours, demonstrating faster workflow compared to conventional MRI systems. The announcement highlights operational efficiency gains for the company's point-of-care imaging platform.
BD launched the Elyra thulium fiber laser system in the US for kidney stone treatment and urologic procedures. The system expands BD's portfolio in the urology market, offering an advanced laser technology for minimally invasive stone management.
Formacoat has introduced a hydrophilic coating platform designed to provide OEMs with an independent supply option for device surface treatments. The solution addresses supply chain resilience and manufacturing flexibility for medical device makers who apply coatings to catheters, guidewires, and similar products.
Neuralink announced a next-generation robotic system designed to perform key procedural steps during implantation of its brain-computer interface devices. The robot represents an advance in surgical automation for BCI procedures, targeting the neurosurgical and implantable device market.
Jupiter Endovascular's Vertex pulmonary embolectomy system met primary endpoints in clinical trials. The device uses transforming fixation technology to improve catheter navigation through the right heart into the pulmonary arteries for treatment of pulmonary embolism.
Labcorp launched MyLabcorp, an AI-powered app designed to help patients understand and navigate their laboratory test results. The move reflects broader industry momentum toward AI-driven patient engagement tools in clinical laboratory services, positioning Labcorp to compete in the growing market for personalized lab result interpretation platforms.
Dukane has deployed its servo ultrasonic welding technology with Melt-Match® to support production of critical components for a wearable glucose monitoring device used in diabetes management. The technology enables precision assembly of the medical device, which is manufactured by a leading medical technology company.
Johnson & Johnson MedTech launched the Shockwave C2 Aero, a fifth-generation intravascular lithotripsy catheter for coronary calcification treatment. The device received FDA approval in June 2025 and rolled out in the United States and Japan in May 2026. The C2 Aero is designed to handle complex calcification patterns and reduce treatment duration compared to earlier generations.
Philips has launched SmartIQ, an AI software tool designed to optimize coronary imaging by balancing image quality with radiation dose reduction. The tool addresses a key clinical trade-off in cardiac imaging procedures, targeting vendors and operators seeking to improve workflow efficiency and patient safety in interventional cardiology settings.
Medtronic has enrolled the first patient in ENDURANCE, a five-year post-approval study for Altaviva, its tibial neurostimulator approved in September. The miniaturized implant (43.7 × 15.7 × 4.5 mm) recently won a 2026 Edison Award. The study will track long-term safety and efficacy outcomes in patients receiving the device for chronic pain management.
PainTEQ announced the US commercial launch of TRAQ, an implant designed for posterior sacroiliac joint fusion. The product launch expands the company's portfolio in the spinal fusion and orthopedic implant market.
Dexcom announced the G8, a next-generation continuous glucose monitoring system during its Investor Day. CEO Jake Leach characterized the device as a completely new product platform, building on the company's existing CGM portfolio for real-time glucose tracking.
Carrot expanded its AI-powered metabolic health platform to include menopause care, integrating personalized guidance with wearable device connectivity. The expansion extends the vendor's existing metabolic health offering into a new clinical area.
Johnson & Johnson launched the Shockwave C2 Aero coronary intravascular lithotripsy (IVL) catheter globally for treatment of calcified coronary artery disease. The device is designed to address calcium buildup in coronary vessels, expanding J&J's interventional cardiology portfolio.
WHOOP, a wearable fitness company, launched AI-enabled features including on-demand video consultations with licensed clinicians for U.S. users and EHR integration via partnership with HealthEx. The additions extend WHOOP's platform beyond fitness tracking into clinical advisory services and healthcare system interoperability.
Mayo Clinic has installed a new electromagnetic induction system (EIS) developed by device startup New Phase to treat cancer using controlled magnetic hyperthermia. The system, installed in November 2025, treated its first U.S. patient in December as part of New Phase's clinical trial. The technology uses magnetic nanoparticles to generate localized heat to target tumors.
Google announced the Fitbit Air, a screenless wearable device for continuous health monitoring that tracks heart rate, sleep stages, blood oxygen, skin temperature, heart rate variability, and irregular heart rhythms including atrial fibrillation detection. The device will integrate with a new Google Health app that consolidates Fitbit and Pixel Watch data across Android and iOS platforms.
Xtant Medical Holdings has commercially launched Trivium Shaped, a new allograft addition to its Trivium bone graft portfolio. The shaped allograft expands the company's offering for surgical applications.
Synergy Spine Solutions has developed the Synergy Disc, a cervical implant designed with ball-and-socket geometry to improve alignment and preserve range of motion in patients with degenerative disc disease. The device employs proprietary geometry combined with established materials. The startup is positioning itself in the cervical spine implant market with a focus on biomechanical design innovation.
Medical Design and Outsourcing's May 2026 issue covers next-generation diabetes sensors and drug delivery devices, highlighting advances beyond traditional fingerstick monitoring. The coverage reflects growing momentum in medtech solutions for diabetes management, addressing the expanding patient population through more active device interventions.
Johnson & Johnson's Ottava soft tissue surgical robot completed a pivotal study demonstrating success in gastric bypass procedures. The development positions J&J to compete in the surgical robotics market, currently led by Intuitive Surgical. The study results support Ottava's clinical utility for bariatric surgery applications.
Oura, a health-tracking ring manufacturer, launched two new hormonal health features—birth control support and menopause insights—for its wearable device. The company also announced a partnership as the official wearable sponsor of the US Open and USTA.
ChronoFlex™ S, a thermoplastic polyurethane (TPU) material, addresses a gap in medical-grade polymers for implantable devices by combining softness with mechanical strength and abrasion resistance. The material is positioned as an alternative to silicone for applications requiring durability under high stress, available in hardness levels previously unavailable in medical-grade TPU formulations suitable for short- and long-term implants.
10 older new products stories available.